Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Enters Into Materials Transfer Agreement for Santersus AG s NucleoCapture and HemoNucleoCapture Devices
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcript February 14, 2024 Aethlon Medical, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome to the Aethlon Medical Third Quarter Fiscal 2024 Earnings and Corporate Update. [Operator […]
Conference Call to be Held Today at 4:30 p.m. ET
SAN DIEGO, Feb. 14, 2024 /PRNewswire/ Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and.